 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
3-27-2024
Insider Buy |
Eric Bjerkholt
CHIEF FINANCIAL OFFICER |
$24.80
CAGR »
|
$49,600.00
2,000 shares |
1-9-2023
Insider Buy |
Lara Longpre
CHIEF DEVELOPMENT OFFICER |
$10.64
CAGR »
|
$10,267.60
965 shares |
3-18-2024
Insider Buy |
Eric Bjerkholt
CHIEF FINANCIAL OFFICER |
$25.80
CAGR »
|
$51,600.00
2,000 shares |
11-9-2023
Insider Buy |
Patrick J. Heron
Director |
$28.30
CAGR »
|
$82,353.00
2,910 shares |
9-13-2023
Insider Buy |
Patrick J. Heron
Director |
$31.02
CAGR »
|
$81,424.88
2,625 shares |
9-12-2023
Insider Buy |
Patrick J. Heron
Director |
$30.44
CAGR »
|
$256,791.22
8,437 shares |
9-11-2023
Insider Buy |
Eric Bjerkholt
Chief Financial Officer |
$29.65
CAGR »
|
$296,492.00
10,000 shares |
8-31-2023
Insider Buy |
Patrick J. Heron
Director and >10% Owner |
$26.25
CAGR »
|
$3,884,763.75
147,991 shares |
11-24-2021
Insider Buy |
Christopher Peetz
President and CEO |
$14.40
CAGR »
|
$100,800.00
7,000 shares |
11-26-2021
Insider Buy |
Ian Clements
Chief Financial Officer |
$14.14
CAGR »
|
$20,505.00
1,450 shares |
12-23-2020
Insider Buy |
Ian Clements
Chief Financial Officer |
$18.65
CAGR »
|
$29,690.80
1,592 shares |
12-23-2020
Insider Buy |
Christopher Peetz
President and CEO |
$18.70
CAGR »
|
$93,480.00
5,000 shares |
3-20-2020
Insider Buy |
Edwin Jonathan Tucker
Chief Medical Officer |
$11.01
CAGR »
|
$49,558.00
4,500 shares |
9-10-2019
Insider Buy |
Laura Brege
Director |
$11.22
CAGR »
|
$112,200.00
10,000 shares |
7-22-2019
Insider Buy |
Peter J. Barris
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
New Enterprise Associates 16, L.P.
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Niall O'donnell
Director |
$15.00
CAGR »
|
$4,500,000.00
300,000 shares |
9-17-2019
Insider Buy |
Laurent Fischer
Director |
$9.39
CAGR »
|
$19,715.61
2,100 shares |
9-6-2019
Insider Buy |
Pamela Vig
Chief Scientific Officer |
$10.97
CAGR »
|
$17,681.76
1,612 shares |
9-6-2019
Insider Buy |
Ian Clements
SVP Finance & Communications |
$11.51
CAGR »
|
$46,039.20
4,000 shares |
9-10-2019
Insider Buy |
Laurent Fischer
Director |
$10.60
CAGR »
|
$49,302.56
4,650 shares |
9-9-2019
Insider Buy |
Christopher Peetz
President and CEO |
$11.02
CAGR »
|
$99,937.88
9,070 shares |
7-22-2019
Insider Buy |
Forest Baskett
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Ali Behbahani
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Carmen Chang
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Anthony A. Florence Jr.
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Mohamad Makhzoumi
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Joshua Makower
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
David M. Mott
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Scott D. Sandell
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Peter W. Sonsini
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Paul Edward Walker
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Frazier Life Sciences IX, L.P.
>10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
Patrick J. Heron
Director and >10% Owner |
$15.00
CAGR »
|
$6,750,000.00
450,000 shares |
7-22-2019
Insider Buy |
James E. Flynn
>10% Owner |
$15.00
CAGR »
|
$4,980,000.00
332,000 shares |
7-22-2019
Insider Buy |
Holdings A/S Novo
>10% Owner |
$15.00
CAGR »
|
$8,625,000.00
575,000 shares |
Also See: Institutional Holders of MIRM
Also See: SEC filings
Below we present the annualized performance delivered by MIRM stock since 3-27-2024 (the date of the most recent
insider purchase). The performance of the investment from the time MIRM insider buying occurred is the ultimate
test of whether insiders were right about MIRM being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/28/2024 |
|
| End date: |
05/01/2024 |
|
| Start price/share: |
$25.12 |
|
| End price/share: |
$25.72 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
2.39% |
|
| Annualized Gain: |
25.64% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$10,239.00 |
|
| Years: |
0.09 |
|
MIRM Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent MIRM insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding MIRM
|
|
Free MIRM Email Alerts:
